Cercar

01/07/2021 Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry
Stephens, C, Robles-Diaz, M, Medina-Caliz, I, Garcia-Cortes, M, Ortega-Alonso, A, Sanabria-Cabrera, J, Gonzalez-Jimenez, A, Alvarez-Alvarez, I, Slim, M, Jimenez-Perez, M, Gonzalez-Grande, R, Fernandez, MC, Casado, M, Soriano, G, Roman, E, Hallal, H, Romero-Gomez, M, Castiella, A, Conde, I, Prieto, M, Moreno-Planas, JM, Giraldez, A, Moreno-Sanfiel, JM, Kaplowitz, N, Lucena, MI, Andrade, RJ, Participating Clinical Ctr. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry. JOURNAL OF HEPATOLOGY. 2021; 75(1)DOI:10.1016/j.jhep.2021.01.029. PMID:33539847. IF:30.083(Q1/1D).
02/11/2022 Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
Chaparro, M, Baston-Rey, I, Fernandez-Salgado, E, Garcia, JG, Ramos, L, Palomares, MTDL, Arguelles-Arias, F, Flores, EI, Cabello, M, Iturria, SR, Ortiz, AN, Charro, M, Ginard, D, Sadornil, CD, Ochoa, OM, Busquets, D, Iyo, E, Casbas, AG, de la Piscina, PR, Bosca-Watts, MM, Arroyo, M, Garcia, MJ, Hinojosa, E, Gordillo, J, Montiel, PM, Jimenez, BV, Ivorra, CQ, Moron, JMV, Huguet, JM, Gonzalez-Lama, Y, Santos, AIM, Amo, VM, Martin-Arranz, MD, Bermejo, F, Cadilla, JM, de Celix, CR, Salazar, PF, San Roman, AL, Jimenez, N, Lopez, SG, Figuerola, A, Jimenez, I, Cerezo, FJM, Taxonera, C, Varela, P, de Francisco, R, Monfort, D, Arriero, GM, Camba, AH, Garcia-Alonso, FJ, Van Domselaar, M, Villarroya, RP, Nunez, A, Moranta, FR, Marin-Jimenez, I, Alonso, VR, Rodriguez, MDM, Camo-Monterde, P, Tercero, IG, Llavat, MN, Garcia, LA, Cruz, DH, Sulleiro, S, Novella, C, Vispo, E, Barreiro-de Acosta, M, Gisbert, JP. Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study. INFLAMMATORY BOWEL DISEASES. 2022; 28(11)DOI:10.1093/ibd/izab357. PMID:35166347. IF:4.900(Q2/3D).
01/10/2022 Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease
Bassegoda O., Olivas P., Turco L., Mandorfer M., Serra-Burriel M., Tellez L., Kwanten W., Laroyenne A., Farcau O., Alvarado E., Moga L., Vuille-Lessard E., Fortea J.I., Ibañez L., Tosetti G., Vanwolleghem T., Larrue H., Burgos-Santamaría D., Stefanescu H., Paternostro R., Cippitelli A., Lens S., Augustin S., Llop E., Laleman W., Trebicka J., Chang J., Masnou H., Zipprich A., Miceli F., Semmler G., Forns X., Primignani M., Bañares R., Puente A., Berzigotti A., Rautou P.E., Villanueva C., Ginès P., Garcia-Pagan J.C., Procopet B., Bureau C., Albillos A., Francque S., Reiberger T., Schepis F., Graupera I., Hernandez-Gea V.. Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease. Clinical Gastroenterology and Hepatology. 2022; 20(10)DOI:10.1016/j.cgh.2021.10.023. PMID:34688952. IF:12.600(Q1/1D).
04/08/2022 Management and Long-term Outcomes of Crohn's Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCU
Barreiro-de Acosta, M, Riestra, S, Calafat, M, Soto, MP, Calvo, M, Rodriguez, ES, Caballol, B, Vela, M, Rivero, M, Munoz, F, de Castro, L, Calvet, X, Garcia-Alonso, FJ, Fornals, AU, Ferreiro-Iglesias, R, Gonzalez-Munoza, C, Chaparro, M, Bujanda, L, Sicilia, B, Alfambra, E, Rodriguez, A, Fernandez, RP, Rodriguez, C, Almela, P, Arguelles, F, Busquets, D, Tamarit-Sebastian, S, Castro, CR, Jimenez, L, Marin-Jimenez, I, Alcaide, N, Fernandez-Salgado, E, Iglesias, A, Ponferrada, A, Pajares, R, Roncero, O, Morales-Alvarado, VJ, Ispizua-Madariaga, N, Sainz, E, Merino, O, Marquez-Mosquera, L, Garcia-Sepulcre, M, Elorza, A, Estrecha, S, Suris, G, Van Domselaar, M, Brotons, A, de Francisco, R, Canete, F, Iglesias, E, Vera, MI, Mesonero, F, Lorente, R, Zabana, Y, Cabriada, JL, Domenech, E, Rodriguez-Lago, I. Management and Long-term Outcomes of Crohn's Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCU. Journal of Crohns & Colitis. 2022; 16(7)DOI:10.1093/ecco-jcc/jjac016. PMID:35104314. IF:8.000(Q1/2D).
01/07/2022 Impact of SARS-CoV-2 Pandemic on Vascular Liver Diseases
Baiges A., Cerda E., Amicone C., Téllez L., Alvarado-Tapias E., Puente A., Fortea J.I., Llop E., Rocha F., Orts L., Ros-Fargas O., Vizcarra P., Zekrini K., Lounes O.A., Touati G., Jiménez-Esquivel N., Serrano M.J., Falgà A., Magaz M., Olivas P., Betancourt F., Perez-Campuzano V., Turon F., Payancé A., Goria O., Rautou P.-E., Hernández-Gea V., Villanueva C., Albillos A., Plessier A., García-Pagán J.-C.. Impact of SARS-CoV-2 Pandemic on Vascular Liver Diseases. Clinical Gastroenterology and Hepatology. 2022; 20(7)DOI:10.1016/j.cgh.2021.12.032. PMID:34968728. IF:12.600(Q1/1D).
01/05/2022 Location, morphology and invasiveness of lateral spreading tumors in the colorectum differ between two large cohorts from an eastern and western country
Guarner-Argente C., Ikematsu H., Osera S., Fraile M., Ibañez B., Marra-López C., Jerusalén-Gargallo C., Alonso Aguirre P.A., Martinez-Ares D., Soto S., Ramos Zabala F., Alvarez-Gonzalez M.A., Rodriguez Sánchez J., Múgica F., Nogales Rincon O., Herreros de Tejada A., Redondo-Cerezo E., Martínez-Cara J., López-Rosés L., Rodriguez-Tellez M., Garcia-Bosch O., de la Peña J., Pellisé M., Rivero-Sanchez L., Saperas E., Pérez-Roldán F., Lopez Viedma B., González-Santiago J.M., Álvarez Delgado A., Cobian C., Pardeiro R., Valdivielso Cortázar E., Colan-Hernandez J., Gordillo J., Kaneko K., Albéniz E.. Location, morphology and invasiveness of lateral spreading tumors in the colorectum differ between two large cohorts from an eastern and western country. Gastroenterologia y Hepatologia. 2022; 45(6)DOI:10.1016/j.gastrohep.2021.07.005. PMID:34400187. IF:(Q/D).
01/05/2022 Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry
Hernández-Camba A., Arranz L., Vera I., Carpio D., Calafat M., Lucendo A.J., Taxonera C., Marín S., Garcia M.J., Marín G.S., Rodríguez E.S., Carbajo A.Y., De Castro M.L., Iborra M., Martin-Cardona A., Rodríguez-Lago I., Busquets D., Bertoletti F., Ausín M.S., Tardillo C., Malaves J.H., Bujanda L., Castaño A., Domènech E., Ramos L., Merino O.. Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry. DIGESTIVE AND LIVER DISEASE. 2022; 54(5)DOI:10.1016/j.dld.2021.10.002. PMID:34862115. IF:4.500(Q2/4D).
01/05/2022 Effect of rifaximin on infections, acute-on-chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA-AH)
Jimenez, C, Ventura-Cots, M, Sala, M, Calafat, M, Garcia-Retortillo, M, Cirera, I, Canete, N, Soriano, G, Poca, M, Simon-Talero, M, Altamirano, J, Lucey, M, Garcia-Tsao, G, Brown, RS, Schwabe, RF, Verna, EC, Schnabl, B, Bosques-Padilla, F, Mathurin, P, Caballeria, J, Louvet, A, Shawcross, DL, Abraldes, JG, Genesca, J, Bataller, R, Vargas, V. Effect of rifaximin on infections, acute-on-chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA-AH). LIVER INTERNATIONAL. 2022; 42(5)DOI:10.1111/liv.15207. PMID:35220659. IF:6.700(Q1/3D).
01/04/2022 Chronic pancreatitis for the clinician. Part 2: Treatment and follow-up. Interdisciplinary Position Paper of the Societat Catalana de Digestologia and the Societat Catalana de Pancrees
Molero X., Ayuso J.R., Balsells J., Boadas J., Busquets J., Casteràs A., Concepción M., Cuatrecasas M., Fernàndez Esparrach G., Fort E., Garcia Borobia F., Ginès À., Ilzarbe L., Loras C., Masachs M., Merino X., Olsina J.J., Puig-Diví V., Salord S., Serrano T., Vaquero E.C.. Chronic pancreatitis for the clinician. Part 2: Treatment and follow-up. Interdisciplinary Position Paper of the Societat Catalana de Digestologia and the Societat Catalana de Pancrees. Gastroenterologia y Hepatologia. 2022; 45(4)DOI:10.1016/j.gastrohep.2021.05.016. PMID:34171422. IF:1.900(Q4/10D).
01/03/2022 Chronic pancreatitis for the clinician. Part 1: Etiology and diagnosis. Interdisciplinary position paper of the Societat Catalana de Digestologia and the Societat Catalana de Pancrees
Molero, X, Ayuso, JR, Balsells, J, Boadas, J, Busquets, J, Casteras, A, Concepcion, M, Cuatrecasas, M, Esparrach, GF, Fort, E, Borobia, FG, Gines, A, Ilzarbe, L, Loras, C, Masachs, M, Merino, X, Olsina, JJ, Puig-Divi, V, Salord, S, Serrano, T, Vaquero, EC. Chronic pancreatitis for the clinician. Part 1: Etiology and diagnosis. Interdisciplinary position paper of the Societat Catalana de Digestologia and the Societat Catalana de Pancrees. Gastroenterologia y Hepatologia. 2022; 45(3)DOI:10.1016/j.gastrohep.2021.05.017. PMID:34157366. IF:1.900(Q4/10D).
01/03/2022 Endoscopy-Related Bleeding and Thromboembolic Events in Patients on Direct Oral Anticoagulants or Vitamin K Antagonists
de Santiago, ER, Aldehuelo, RS, Pons, FR, Escaja, CR, Fernandez-Esparrach, G, Canete-Ruiz, A, Aracil, CF, Perez-Corte, D, Leon, RR, Marcos-Prieto, HM, Delgado-Guillena, PG, Garcia-Rodriguez, A, Guarner-Argente, C, Muriel, A, de la Fuente-Briongos, E, de Paredes, AGG, Parejo-Carbonell, S, Tellez, L, Senosiain-Lalastra, C, Burgos-Santamaria, D, Aicart-Ramos, M, Munoz, BM, Penas-Garcia, B, Pagano, G, Urquiza, GC, Ferreruela, MU, de Jorge-Turrion, MA, Barreiro-Alonso, E, Fraile-Lopez, M, Gomez-Outomuro, A, Altamirano, MI, Esteban, MN, Ruiz-Andreu, M, Arribas-Anta, J, de Frutos, D, Herreros-de-Tejada, A, Arias-Rivera, ML, Roldan-Fernandez, M, Martin, AFM, Zamora, J, Vazquez-Sequeiros, E, Albillos, A. Endoscopy-Related Bleeding and Thromboembolic Events in Patients on Direct Oral Anticoagulants or Vitamin K Antagonists. Clinical Gastroenterology and Hepatology. 2022; 20(3)DOI:10.1016/j.cgh.2020.11.037. PMID:33279783. IF:12.600(Q1/1D).
01/02/2022 Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients
Gutierrez, A, Zapater, P, Ricart, E, Gonzalez-Vivo, M, Gordillo, J, Olivares, D, Vera, I, Manosa, M, Gisbert, JP, Aguas, M, Sanchez-Rodriguez, E, Bosca-Watts, M, Laredo, V, Camps, B, Marin-Jimenez, I, Zabana, Y, Martin-Arranz, MD, Munoz, R, Navarro, M, Sierra, E, Madero, L, Vela, M, Perez-Calle, JL, Sainz, E, Calvet, X, Arias, L, Morales, V, Bermejo, F, Fernandez-Salazar, L, Van Domselaar, M, De Castro, L, Rodriguez, C, Munoz-Villafranca, C, Lorente, R, Rivero, M, Iglesias, E, Herreros, B, Busquets, D, Riera, J, Martinez-Montiel, MP, Roldon, M, Roncero, O, Hinojosa, E, Sierra, M, Barrio, J, De Francisco, R, Huguet, J, Merino, O, Carpio, D, Ginard, D, Munoz, F, Marta, P, Almela, P, Argueelles-Arias, F, Alcain, G, Luis, B, Mancenido, N, Lucendo, AJ, Varela, P, Rodriguez-Lago, I, Ramos, L, Laura, S, Sese, E, Acosta, MBD, Domenech, E, Frances, R. Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients. Frontiers in Medicine. 2022; 9DOI:10.3389/fmed.2022.823900. PMID:35178413. IF:3.900(Q2/4D).
01/01/2022 Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNF alpha used for the treatment of IBD: Results from the VERNE study
Batista, G, Marin-Jimenez, I, Fores, A, Garcia-Planella, E, Arguelles-Arias, F, Tagarro, I, Fernandez-Nistal, A, Montoto, C, Aparicio, J, Aguas, M, Santos-Fernandez, J, Bosca-Watts, MM, Ferreiro-Iglesias, R, Merino, O, Aldeguer, X, Corttes, X, Sicilia, B, Mesonero, F, Barreiro-de Acosta, M. Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNF alpha used for the treatment of IBD: Results from the VERNE study. DIGESTIVE AND LIVER DISEASE. 2022; 54(1)DOI:10.1016/j.dld.2021.06.005. PMID:34244110. IF:4.500(Q2/4D).
01/01/2022 Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry
Zabana, Y, Marin-Jimenez, I, Rodriguez-Lago, I, Vera, I, Martin-Arranz, MD, Guerra, I, Gisbert, JP, Mesonero, F, Benitez, O, Taxonera, C, Ponferrada-Diaz, A, Piqueras, M, Lucendo, AJ, Caballol, B, Manosa, M, Martinez-Montiel, P, Bosca-Watts, M, Gordillo, J, Bujanda, L, Mancenido, N, Martinez-Perez, T, Lopez, A, Rodriguez-Gutierrez, C, Garcia-Lopez, S, Vega, P, Rivero, M, Melcarne, L, Calvo, M, Iborra, M, de-Acosta, MB, Sicilia, B, Barrio, J, Perez, JL, Busquets, D, Perez-Martinez, I, Navarro-Llavat, M, Hernandez, V, Argueelles-Arias, F, Esteso, FR, Meijide, S, Ramos, L, Gomollon, F, Munoz, F, Suris, G, de Zarate, JO, Huguet, JM, Llao, J, Garcia-Sepulcre, MF, Sierra, M, Dura, M, Estrecha, S, Coronel, AF, Hinojosa, E, Olivan, L, Iglesias, E, Gutierrez, A, Varela, P, Rull, N, Gilabert, P, Hernandez-Camba, A, Brotons, A, Ginard, D, Sese, E, Carpio, D, Aceituno, M, Cabriada, JL, Gonzalez-Lama, Y, Jimenez, L, Chaparro, M, Roman, ALS, Alba, C, Plaza-Santos, R, Mena, R, Tamarit-Sebastian, S, Ricart, E, Calafat, M, Olivares, S, Navarro, P, Bertoletti, F, Alonso-Galan, H, Pajares, R, Olcina, P, Manzano, P, Domenech, E, Esteve, M. Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry. Journal of Clinical Medicine. 2022; 11(2)DOI:10.3390/jcm11020421. PMID:35054116. IF:3.900(Q2/4D).
01/12/2021 Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis
de Paredes, AGG, Villanueva, C, Blanco, C, Genesca, J, Manicardi, N, Garcia-Pagan, JC, Calleja, JL, Aracil, C, Morillas, RM, Poca, M, Penas, B, Augustin, S, Abraldes, JG, Alvarado, E, Royo, F, Garcia-Bermejo, ML, Falcon-Perez, JM, Banares, R, Bosch, J, Gracia-Sancho, J, Albillos, A. Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis. Jhep Reports. 2021; 3(6)DOI:10.1016/j.jhepr.2021.100368. PMID:34712934. IF:9.917(Q1/2D).
01/11/2021 Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry
Chaparro, M, Garre, A, Iborra, M, Sierra-Ausin, M, Barreiro-de Acosta, M, Fernandez-Clotet, A, de Castro, L, Bosca-Watts, M, Casanova, MJ, Lopez-Garcia, A, Lorente, R, Rodriguez, C, Carbajo, AY, Arroyo, MT, Gutierrez, A, Hinojosa, J, Martinez-Perez, T, Villoria, A, Bermejo, F, Busquets, D, Camps, B, Canete, F, Mancenido, N, Monfort, D, Navarro-Llavat, M, Perez-Calle, JL, Ramos, L, Rivero, M, Angueira, T, Monterde, PC, Carpio, D, Garcia-de-la-Filia, I, Gonzalez-Munoza, C, Hernandez, L, Huguet, JM, Morales, VJ, Sicilia, B, Vega, P, Vera, I, Zabana, Y, Nos, P, Alvarez, PS, Calvino-Suarez, C, Ricart, E, Hernandez, V, Minguez, M, Marquez, L, Cruz, DH, Iturria, SR, Barrio, J, Gargallo-Puyuelo, C, Frances, R, Hinojosa, E, del Moral, M, Calvet, X, Algaba, A, Aldeguer, X, Guardiola, J, Manosa, M, Pajares, R, Piqueras, M, Garcia-Bosch, O, Serrano, PL, Castro, B, Lucendo, AJ, Montoro, M, Ortiz, EC, Mesonero, F, Garcia-Planella, E, Fuentes, DA, Bort, I, Delgado-Guillena, P, Arias, L, Iglesias, A, Calvo, M, Esteve, M, Domenech, E, Gisbert, JP. Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry. Journal of Crohns & Colitis. 2021; 15(11)DOI:10.1093/ecco-jcc/jjab070. PMID:33860795. IF:10.020(Q1/2D).
01/11/2021 Effects of Albumin on Survival after a Hepatic Encephalopathy Episode: Randomized Double-Blind Trial and Meta-Analysis
Ventura-Cots, M, Simon-Talero, M, Poca, M, Ariza, X, Masnou, H, Sanchez, J, Llop, E, Canete, N, Martin-Llahi, M, Amador, A, Martinez, J, Clemente-Sanchez, A, Puente, A, Torrens, M, Alvarado-Tapias, E, Napoleone, L, Miquel-Planas, M, Ardevol, A, Rodrigo, MC, Calleja, JL, Sole, C, Soriano, G, Genesca, J. Effects of Albumin on Survival after a Hepatic Encephalopathy Episode: Randomized Double-Blind Trial and Meta-Analysis. Journal of Clinical Medicine. 2021; 10(21)DOI:10.3390/jcm10214885. PMID:34768404. IF:4.964(Q2/4D).
01/11/2021 Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study
Reig, A, Alvarez-Navascues, C, Vergara, M, Gomez-Dominguez, E, Gallego-Moya, A, Perez-Medrano, IM, Fabrega, E, Hernandez-Guerra, M, Berenguer, M, Estevez, P, Arencibia, A, Morillas, RM, Horta, D, Albillos, A, Casado, M, De la Cruz, G, Fernandez-Bonilla, E, Molina, E, Hijona, L, Diago, M, Fernandez-Rodriguez, CM, Gonzalez-Santiago, JM, Sala, M, Gomez-Camarero, J, Romero-Gomez, M, Suarez, F, Vargas, V, Ferre-Aracil, C, Andrade, RJ, Chahri, N, Pares, A. Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2021; 116(11)DOI:10.14309/ajg.0000000000001343. PMID:34158466. IF:12.045(Q1/1D).
07/03/2023 Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding
Rudler, M, Hernandez-Gea, V, Procopet, BD, Giraldez, A, Amitrano, L, Villanueva, C, Ibanez, L, Silva, G, Genesca, J, Bureau, C, Trebicka, J, Banares, R, Krag, A, Llop, E, Laleman, W, Palazon, JM, Castellote, J, Rodrigues, S, Gluud, LL, Ferreira, CN, Canete, N, Rodriguez, M, Ferlitsch, A, Mundi, JL, Gronbaek, H, Hernandez-Guerra, M, Sassatelli, R, Dell'era, A, Senzolo, M, Abraldes, JG, Romero-Gomez, M, Zipprich, A, Casas, M, Masnou, H, Larrue, H, Primignani, M, Nevens, F, Calleja, JL, Schwarzer, R, Jansen, C, Robic, MA, Conejo, I, Gonzalez, JM, Catalina, MV, Albillos, A, Alvarado, E, Guardascione, MA, Mallet, M, Tripon, S, Casanovas, G, Bosch, J, Garcia-Pagan, JC, Thabut, D. Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding. GUT. 2023; 72(4)DOI:10.1136/gutjnl-2022-326975. PMID:36328772. IF:23.100(Q1/1D).
27/01/2023 Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry
Casas-Deza D., Lamuela-Calvo L.J., Gomollón F., Arbonés-Mainar J.M., Caballol B., Gisbert J.P., Rivero M., Sánchez-Rodríguez E., García L.A., Casbas A.G., Merino O., Márquez L., Laredo V., Martín-Arranz M.D., Serrano P.L., Menéndez S.R., González-Muñoza C., Parga, LD, Moya M.C., Fuentes-Valenzuela E., Esteve M., Iborra M., Gil M.D., Barreiro-De Acosta, M, Lorente-Poyatos R.H., Mancenido, N, Calafat M., Rodríguez-Lago I., Capo J.G., Payeras M.A., Alvarado, VJM, Tardillo C., Bujanda L., Munoz-Nunez, JF, Nieto Y.B., Bermejo F., Almela P., Navarro-Llavat M., Montiel P.M., Gutiérrez C.R., Van Domselaar M., Sesé E., Pérez T.M., Ricart E., Chaparro M., García M.J., López-Sanromán A., Sicilia B., Orts B., López-García A., Martín-Arranz E., Pérez-Calle J.L., de Francisco R., García-Planella E., Domenech, E, García-López S.. Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry. Journal of Crohns & Colitis. 2023; 17(1)DOI:10.1093/ecco-jcc/jjac108. PMID:35913456. IF:8.300(Q1/1D).